Mesoblast, a leader in allogeneic cellular medicines for inflammatory diseases, has Dr. George as its largest shareholder, according to a Feb. 23 press release.
Dr. George has a background in medical science with experience in operations, having built an ASC startup into a billion-dollar organization, according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
